Richard Eglen, PhD

Dr. Richard M. Eglen is Chief Scientific Officer responsible for all R&D activities at DiscoveRx. He joined Syntex Research in 1987, holding several senior management positions, leading to his appointment as Vice President and Director of the Institute of Pharmacology in 1993. Following the acquisition of Syntex by Roche in 1994, Dr. Eglen participated in the design and implementation of Roche Bioscience, where he held the position of Vice President and Director of the Center for Biological Research. In 1997, he was also appointed as global coordinator of High Throughput Screening for Roche. In 2000, Dr. Eglen joined LJL Biosystems as Senior Vice President of Assays and Reagents where he was responsible for the development and implementation of the reagent assay business strategy focused on high throughput screening. Dr. Eglen is the author of over 250 peer-reviewed papers, and several book chapters. He is also the inventor on several patents. He is a member of numerous professional organizations and member of several journal editorial boards. He was recently elected to the Board of Directors of the Society for Biomolecular Sciences. Dr. Eglen holds a PhD in Pharmacology.